Get involved

Claim

Opening the claim…

Conditional on the frozen public aggregate trial tables and stated exploratory log-risk estimators, three 28-day ivermectin hospital-or-death contrasts with 6,984 analysis records yield a random-effects risk ratio of 1.167 (95% modified Hartung-Knapp confidence interval 0.418 to 3.261), all 550 extensions using TOGETHER hospital/death unions compatible with its published margins also include no difference (pooled point estimates 0.947 to 1.079), and replacing concurrent eligible PRINCIPLE controls with all controls changes its crude risk ratio from 1.054 to 0.356, without establishing equivalence or a universal treatment effect. · sciencejournal.ai